488 related articles for article (PubMed ID: 34220816)
1. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
Front Immunol; 2021; 12():669812. PubMed ID: 34220816
[TBL] [Abstract][Full Text] [Related]
2. In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.
Omoniyi AA; Adebisi SS; Musa SA; Nzalak JO; Bauchi ZM; Bako KW; Olatomide OD; Zachariah R; Nyengaard JR
Sci Rep; 2022 May; 12(1):8736. PubMed ID: 35610299
[TBL] [Abstract][Full Text] [Related]
3. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
5. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus.
Khan MSA; Nain Z; Syed SB; Abdulla F; Moni MA; Sheam MM; Karim MM; Adhikari UK
Mol Cell Probes; 2021 Feb; 55():101693. PubMed ID: 33388416
[TBL] [Abstract][Full Text] [Related]
6. In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever.
Alam R; Samad A; Ahammad F; Nur SM; Alsaiari AA; Imon RR; Talukder MEK; Nain Z; Rahman MM; Mohammad F; Karpiński TM
BMC Med; 2023 Feb; 21(1):36. PubMed ID: 36726141
[TBL] [Abstract][Full Text] [Related]
7. Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach.
Nosrati M; Behbahani M; Mohabatkar H
J Biomed Inform; 2019 May; 93():103160. PubMed ID: 30928513
[TBL] [Abstract][Full Text] [Related]
8. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
[TBL] [Abstract][Full Text] [Related]
10. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
Nosrati M; Mohabatkar H; Behbahani M
Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
[TBL] [Abstract][Full Text] [Related]
11. Identification of functional epitopes of structural proteins and in-silico designing of dual acting multiepitope anti-tick vaccine against emerging Crimean-Congo hemorrhagic fever virus.
Shrivastava N; Verma A; Dash PK
Eur J Pharm Sci; 2020 Aug; 151():105396. PubMed ID: 32479862
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
[TBL] [Abstract][Full Text] [Related]
13. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
[TBL] [Abstract][Full Text] [Related]
14. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
Zivcec M; Safronetz D; Scott DP; Robertson S; Feldmann H
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006628. PubMed ID: 30011277
[TBL] [Abstract][Full Text] [Related]
15. Development of Multi-epitope Based Subunit Vaccine Against Crimean-Congo Hemorrhagic Fever Virus Using Reverse Vaccinology Approach.
Imran MA; Islam MR; Saha A; Ferdousee S; Mishu MA; Ghosh A
Int J Pept Res Ther; 2022; 28(4):124. PubMed ID: 35789799
[TBL] [Abstract][Full Text] [Related]
16. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
[TBL] [Abstract][Full Text] [Related]
17. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model.
Hawman DW; Ahlén G; Appelberg KS; Meade-White K; Hanley PW; Scott D; Monteil V; Devignot S; Okumura A; Weber F; Feldmann H; Sällberg M; Mirazimi A
Nat Microbiol; 2021 Feb; 6(2):187-195. PubMed ID: 33257849
[TBL] [Abstract][Full Text] [Related]
18. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.
Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL
Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060
[TBL] [Abstract][Full Text] [Related]
19. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
[TBL] [Abstract][Full Text] [Related]
20. An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean-Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target.
Shah SZ; Jabbar B; Mirza MU; Waqas M; Aziz S; Halim SA; Ali A; Rafique S; Idrees M; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
